David Utz

David Utz

Disclosures:

Talks by David Utz

Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument

Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument

Posted by | Jan 2020

Robert E. Donohue, MD, argues against urologists adhering to the National Comprehensive Cancer Network (NCCN) Prostate Cancer Screening and Early Detection Guidelines. He proposes his own definitive answers to controversial questions relating to the use of digital rectal exams and PSA tests in baseline evaluation, indications for biopsy and biopsy technique, the age for initiation and discontinuation of testing, the frequency of testing, screening in high-risk populations, and which biomarkers to use. 

Read More
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective

Prostate Cancer Screening & Genetic Testing: The NCCN Perspective

Posted by | Jan 2020

J. Kellogg Parsons, MD, MHS, discusses the rationale behind the National Comprehensive Cancer Network (NCCN) guidelines on prostate cancer screening and how they fit in with currently available genetic testing. He describes the multi-disciplinary makeup of the NCCN, details considerations that led to their recommendations on when men should be screened and in which circumstances, and outlines opportunities to improve the guidelines through standardization, coordination with other organizations, and improved treatment algorithms.

Read More
Prevalence of Criteria for Genetic Testing According to the National Comprehensive Cancer Network Guidelines in a Contemporary Cohort of Post-Prostatectomy Men with Intermediate and High-Risk Prostate Cancer: The Henry Ford Health System Experience

Prevalence of Criteria for Genetic Testing According to the National Comprehensive Cancer Network Guidelines in a Contemporary Cohort of Post-Prostatectomy Men with Intermediate and High-Risk Prostate Cancer: The Henry Ford Health System Experience

Posted by | Oct 2019

Zade Roumayah details the results of a study at the Henry Ford Health System examining the prevalence of National Comprehensive Cancer Network criteria for genetic testing in post-prostatectomy men who had intermediate- to high-grade prostate cancer. With around a 50% response rate, the team found that around 27% of men fit these criteria, in categories including family history of break & ovarian cancer, having two or more family members with a variety of cancer types, and personal cancer history.

Read More

Join the GRU Community

- Why Join? -